XSPRAY fundamentals
An in-depth look to XSPRAY PHARMA AB operating, investing, and financing activities
XSPRAY free cash flow for Q4 23 is -36.8 M SEK. For 2023, XSPRAY free cash flow was -207.52 M SEK and operating cash flow was -203.28 M SEK.
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
0.00
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: SEK
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
TTM